The First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget
Update: 2021-11-19
Description
FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King discuss more developments in the race to bring COVID-19 antivirals to patients, Bristol Myers Squibb’s long term outlook and the pending departure of veteran Al Sandrock as Biogen’s head of R&D.
Comments 
In Channel




